Clinical trial GO29674
A Phase Ib, Open-Label, Dose-escalation Study of the safety and Pharmacokinetics of MOXR0916 and MPDL3280A in Patients with Locally Advanced or Metastatic Solid Tumors
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Genentech-Roche |
EudraCT Identifier | 2015-000516-18 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02410512 |
Inclusion criteria | any line |
Last update |